Concepedia

Lorenzo Falchi

LF

53

Publications

2.2K

Citations

23

H-Index

2005

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

AbbVie (United States)

Genmab (United States)

Ronald Reagan UCLA Medical Center

University of California, Los Angeles

Lorenzo Falchi is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2005–2024

53

Publications

53

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

Connie Lee Batlevi, Fushen Sha, Anna Alperovich et al. · Blood Cancer Journal · 2020 · 185 citations · Full text

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder et al. · Journal of Clinical Oncology · 2021 · 183 citations · Full text

Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study

Lorenzo Falchi, Helen Ma, Sandra E. Klein et al. · Blood · 2020 · 174 citations · Full text

Correlation between FDG/PET, histology, characteristics, and survival in 332 patients with chronic lymphoid leukemia

Lorenzo Falchi, Michael J. Keating, Edith M. Marom et al. · Blood · 2014 · 146 citations · Full text

A phase 1 study of romidepsin and pralatrexate reveals marked activity in relapsed and refractory T-cell lymphoma

Jennifer E. Amengual, Renee Lichtenstein, Jennifer Kimberly Lue et al. · Blood · 2017 · 128 citations · Full text

Rows per page

1–5 of 53